Atlas Trials

Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks

Clinical trial NCT02706015 · WITHDRAWN

Trial details

NCT number
NCT02706015
Sponsor
Ache Laboratorios Farmaceuticos S.A.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Migraine Headache
Start date
2020-10-01
Primary completion
2021-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.